Thymoquinone (Figure 1), a bioactive compound classified as a monoterpene, shares some mechanistic pathways with these compounds, such as NF-κB signalling, supporting its potential role in AMD prevention [28]. This evidence concerns the gene NFKB1 and age-related macular degeneration.